Cargando…
Astodrimer sodium and bacterial vaginosis: a mini review
Bacterial vaginosis (BV) is the most common vaginal infection affecting women of childbearing age, and is associated with a substantial burden on women’s physical, emotional, sexual and social lives, as well as being linked to a number of gynaecological and obstetrical complications and adverse preg...
Autores principales: | Mendling, Werner, Holzgreve, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300565/ https://www.ncbi.nlm.nih.gov/pubmed/35246717 http://dx.doi.org/10.1007/s00404-022-06429-z |
Ejemplares similares
-
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2021) -
Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study
por: Diebold, Ruth, et al.
Publicado: (2021) -
An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review
por: Mendling, Werner, et al.
Publicado: (2019) -
Bacterial Vaginosis: A Comprehensive Narrative on the Etiology, Clinical Features, and Management Approach
por: Khedkar, Rutuja, et al.
Publicado: (2022) -
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
por: Waldbaum, Arthur S., et al.
Publicado: (2020)